Charles River Laboratories International, Inc. (CRL) key performance indicators and operating metrics (9 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Discovery and Safety Assessment Segment Revenue | 596.9M | FY2026-Q1 |
| Manufacturing Solutions Revenue | 190.5M | FY2026-Q1 |
| Non-GAAP Diluted Earnings Per Share | 2.06 USD_per_share | FY2026-Q1 |
| Research Models and Services Segment Revenue | 208.4M | FY2026-Q1 |
| Non-GAAP Operating Margin (Discovery and Safety Assessment) | 21.00 percent | FY2026-Q1 |
| Non-GAAP Operating Margin (Manufacturing Solutions) | 25.90 percent | FY2026-Q1 |
| Non-GAAP Operating Margin (Research Models and Services) | 24.70 percent | FY2026-Q1 |
| Non-GAAP Net Income | 101.7M | FY2026-Q1 |
| Non-GAAP Operating Margin (Consolidated) | 16.30 percent | FY2026-Q1 |
Back to CRL overview · CRL earnings · CRL holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.